FlyPharma Conference Europe 2022 shares the latest supply chain challenges and advice for better industry collaboration
On 20-21 September 2022, the FlyPharma Conference Europe made a welcome return as a live, in-person event
Read More
Author: John Pinching
Eli Lilly receives marketing authorisation for baricitinib
Treatment involves adult patients with severe alopecia areata
Read More
‘Junk’ DNA may hold the key to neurological disorders
University of Lincoln and the University of Sheffield are researching how DNA could be repaired
Read More
Santhera submits marketing authorisation application for vamorolone
The anti-inflammatory treatment is for Duchenne muscular dystrophy
Read More
LEO Pharma launches ‘AD Days Around the World’
Events will raise awareness around the impact of atopic dermatitis across cultures
Read More- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
- Alzecure shares new preclinical data on NeuroRestore ACD856 at AD/PD conference
- Samsung Bioepis signs partnership with Sandoz for next‑generation biosimilars
